Astera Labs (NASDAQ:ALAB) Stock Price Up 3.4% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price shot up 3.4% during trading on Monday. The company traded as high as $365.24 and last traded at $362.34. Approximately 3,232,048 shares were traded during trading, a decline of 38% from the average session volume of 5,184,580 shares. The stock had previously closed at $350.33.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Fubon initiated coverage with a $500 price target, suggesting further potential upside and reflecting confidence in Astera Labs’ role in the expanding AI data-center connectivity market. Fubon starts coverage with USD 500 target for Astera Labs stock
• Positive Sentiment: The recent rally is being attributed to surging demand for AI-related connectivity solutions. Astera Labs’ strong year-to-date performance underscores investor enthusiasm for its exposure to rack-scale AI infrastructure. Why Astera Labs Is Rallying Today
• Neutral Sentiment: Astera Labs will report third-quarter 2026 results after the market closes on November 3, 2026. The announcement gives investors a forthcoming earnings catalyst, but it does not provide updated financial results or guidance. Astera Labs Announces Conference Call to Review Third Quarter 2026 Financial Results
• Negative Sentiment: Zacks Research downgraded ALAB from “strong buy” to “hold.” The change follows an approximately 118% year-to-date gain and reflects concern that the stock’s elevated valuation, rising costs and intensifying competition may limit additional returns. Zacks Research Downgrades Astera Labs to Hold
• Negative Sentiment: Competitive pressure remains a risk as Marvell’s partnerships with Nvidia and Microsoft could strengthen its challenge to Astera Labs and Broadcom in AI connectivity markets. Marvell’s Alliance With Nvidia and Microsoft

Wall Street Analyst Weigh In

ALAB has been the subject of a number of recent analyst reports. Susquehanna upped their price objective on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. TD Cowen cut their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday. Needham & Company LLC increased their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada raised their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Twelve research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Stock Performance

The business’s 50 day moving average is $313.22 and its two-hundred day moving average is $286.60. The firm has a market capitalization of $67.63 billion, a PE ratio of 192.97 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the business posted $0.44 earnings per share. The business’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 396,059 shares of company stock worth $122,605,660 in the last three months. 10.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Astera Labs

Large investors have recently modified their holdings of the business. Greenleaf Trust boosted its stake in shares of Astera Labs by 1.8% during the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after purchasing an additional 36 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in Astera Labs by 74.5% in the second quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after buying an additional 41 shares in the last quarter. Glenmede Trust Co. NA raised its stake in Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the second quarter worth about $25,000. Finally, Integrated Wealth Concepts LLC lifted its holdings in Astera Labs by 0.7% in the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock worth $3,384,000 after buying an additional 52 shares during the period. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.